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Longitudinal study of cytokine production 
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It has been suggested that for compensation of this shift in the balance of the specific 
immune response, the inflammatory response is activated during pregnancy (Sacks et al. 
1998; Veenstra van Nieuwenhoven et al. 2002). Circulating monocytes (and granulocytes) 
have activated phenotypes (e.g. up-regulation of the endotoxin-receptor CD14, and 
other activation markers, like CD163 and CD206 (Porcheray et al. 2005). These changes 
in the inflammatory response resemble the changes in the inflammatory response seen 
in sepsis (Sacks et al. 1998). Monocytes do not only show phenotypical activation, but 
also functional activation. This functional activation is shown by changes in cytokine 
production of ex vivo activated pregnant monocytes compared with non-pregnant 
monocytes, indicating activation of circulating pregnant monocytes (Veenstra van 
Nieuwenhoven et al. 2003; Sacks et al. 2003).  
 
The shift towards a type 2 cytokine response during pregnancy is essential for normal 
pregnancy. This becomes obvious from studies performed in patients with recurrent 
miscarriage and preeclampsia. In recurrent miscarriage patients the shift from type  1 
cytokine production towards type 2 cytokine production, which characterizes normal 
pregnancy, does not occur (Piccinni et al. 1998; Piccinni et al. 2001). The severe forms of 
preeclampsia are also associated with a shift towards type 1 cytokine production as 
compared with normal pregnant women (Saito et al. 1999b). Mild, late onset 
preeclampsia seems to be associated with a further shift towards type 2 cytokine 
production as compared with normal pregnancy (Veenstra van Nieuwenhoven et al. 2008). 
Moreover, during preeclampsia, the inflammatory system appears to be even more 
activated (both phenotypically and functionally) than during normal pregnancy (Sakai et 
al. 2002; Luppi and Deloia 2006; Veenstra van Nieuwenhoven et al. 2008). 
 
From the above, it is clear that the pregnancy-induced changes in the immune system 
are crucial for a normal pregnancy. It seems likely, however, that the pregnancy-
induced changes in the immune response vary during the course of pregnancy, since 
the foetal-maternal contact also varies during the course of pregnancy (Wilczynski 2005). 
During early pregnancy there is local interaction in the decidua between immune cells 
and invading syncytiotrophoblast followed by invading extravillous cytotrophoblast 
(Moffet-King et al. 2002). This phase will end at some point during the third trimester 
when invasive trophoblast regresses and decidual lymphocytes degenerate (Brosens et al.  
1972; Haller et al. 1993). At the later stages of pregnancy, with the development of the 
uteroplacental circulation at approximately 8-9 weeks of pregnancy, interaction 
between circulating maternal immune cells and syncytiotrophoblast starts (Jauniaux et al. 
2000). The extent of this interaction is closely related to the growth of the placenta, i.e. 
villous area, until the end of the pregnancy. The total area of the foetal-maternal 
contact can rise to 20 square metres.  
 
During recent years, research into maternal immune response has merely focussed on 
the third trimester of pregnancy compared with non-pregnant women. It is this phase 
of pregnancy, which is associated with a shift from type 1 cytokine production (related 
to cellular immune response) towards type 2 cytokine production (related to a humoral 
immune response) (Mosmann et al. 1989; Wegmann et al. 1993; Veenstra van Nieuwenhoven et al. 
2002; Veenstra van Nieuwenhoven et al. 2003). To get better insight into the adaptation of the 
immune response during this period of pregnancy, we measured variations in white 
blood cell populations as well as lymphocyte, NK cell and monocyte cytokine 
production after ex vivo stimulation during the course of normal pregnancy. 
Therefore, every 5 weeks blood samples were taken from normal pregnant women, 
starting at 10 weeks of pregnancy. In these samples the cytokine production of the 






































A pregnant woman has a well functioning immune system which protects her from 
infections. Despite the fact that the foetus is semi-allogeneic, i.e. expresses paternally 
derived antigens, it is not rejected by the mother. Extensive research has focussed 
around this paradox of pregnancy in the field of reproductive immunology for the last 
fifty years. Understanding the physiological mechanisms behind this paradox of 
pregnancy has high clinical implications for the treatment of not only complicated 
pregnancies, such as preeclampsia or spontaneous abortions, but also for fertility 
treatment and even cell- and organ transplantation.  
Although the mother has a well functioning immune response, this response has 
changed as compared with normal non-pregnant women. It has been shown that during 
normal pregnancy, a shift from type 1 cytokine production towards type 2 cytokine 
production takes place (Sabahi et al. 1995; Saito et al. 1999a; Shimaoka et al. 2000; Veenstra van 
Nieuwenhoven et al. 2002).  
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peripheral white blood cells after in vitro stimulation was measured as well as the 





Material and methods 
 
List of reagents for cell activation and cell staining: 
Monensin (Sigma); phorbol myristate acetate (PMA; Sigma); FACS tm lysing solution 
(Becton Dickinson); FACS tm permeabilizing solution (Becton Dickinson); Calcium 
ionophore A-23187 (Sigma); Complete RPMI 1640 (Gibco) supplemented with 
60μg/mL Gentamycin; Washing buffer (phosphate buffered saline with 0.5% Bovine 
Serum Albumin and 0.1% NaN3); Fixation buffer (0.5% paraformaldehyde in 
phosphate buffered saline); LPS (lipopolysaccharide, 055.B5 E.coli, Wittaker). 
 
Subjects: 
After obtaining institutional approval of the local ethics committee, and after signing 
informed consent, blood samples were taken from healthy women who were not 
pregnant (n = 17; age range: 18-35 years) with a menstrual cycle length between 26 
and 32 days (hospital staff and students) and healthy nulliparous as well as healthy 
multiparous women (n = 10; age range: 18-35 years) recruited from our out-patient 
clinic for midwives. The samples were taken at 10, 15, 20, 25, 30, 35 and 40 weeks of 
pregnancy. Seven patients delivered before 40 weeks of pregnancy, none delivered 
preterm or overdue. These women were regularly checked by their midwives and their 
pregnancy remained normal. All women delivered at term from a healthy baby (2960-
3900 g). Exclusion criteria were evidence of treatment with antibiotics or flu-like 
symptoms within 14 days of the blood sampling as well as the presence of any known 
diseases. Also twin pregnancies were excluded and patients with a history of recurrent 
abortions. Blood samples (20 mL) were obtained in 2 vacutainer tubes, one of which 
contained sodium heparin, and which was used to evaluate intracellular cytokine 
production; the other contained EDTA and was used for white blood cell (WBC) 
counts (using a microcellcounter: Model Sysmex F800, TOA Medical Electronics CO, 
Ltd, Kobe, Japan). Blood samples of eleven healthy women in the follicular phase 




The following monoclonal antibodies were used; unless stated otherwise, all 
purchased from IQ Products Groningen, The Netherlands: Cy-Q labeled mouse anti-
human CD3 (clone B-B11); Fluorescein isothiocyanate (FITC) labeled mouse anti-
human CD8 (clone MCD8); FITC-labeled mouse anti-human CD14 (clone UCHM1); 
Phycoerythrin (PE) labeled mouse anti-human IFNγ (clone 45-15), PE-labeled mouse-
anti-human IL2 (clone N7-48A), PE-labeled mouse anti-human IL4 (clone 8F-12), 
PE-labeled mouse anti-human IL10 (clone B-N10), PE-labeled mouse isotype control 
IgG1 (clone MCG1); FITC-labeled mouse anti-human CD94 (clone HP-3B1; Coulter 
Immunotech, Hamburg, Germany); Phycoerythrin (PE) labeled mouse anti-human 
TNFα (clone Mab11; Pharmingen), PE-labeled mouse-anti-human IL12 (clone C11.5; 
Pharmingen), PE-labeled mouse anti-human IL1β (clone AS10; Becton Dickinson). 
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Incubation: 
Immediately following sampling, 3 mL heparinized whole blood was mixed with 3 
mL of RPMI and stimulated with PMA (40 nM) and calcium ionophore (2 nM) in a 
sterile polystyrene tube for stimulation of lymphocytes and NK cells. Another 3 mL 
heparinized whole blood was mixed with 3 mL of RPMI and stimulated with 2 µg/mL 
LPS in a sterile polystyrene tube for stimulation of monocytes and 3 mL of 
heparinized whole blood was used as unstimulated control and only mixed with 3 mL 
of RPMI in a sterile polystyrene tube. Samples were incubated for 4 hours at 37 °C 
and 5% CO2. In both the stimulated and unstimulated samples, monensin (3μM) was 
added to enable accumulation of the cytokines in the golgicomplex by interrupting 
intracellular processes (Jung et al. 1993).   
  
Sample labeling for measuring cytokines in monocytes: 
After stimulation with LPS or saline, both samples were aliquoted (0.2 mL per tube) 
and incubated with anti-CD14 (5μL) (for identifying monocytes) for 30 minutes. After 
that, 1 mL lysing buffer was added to all tubes for lysing of red blood cells. After 5 
minutes incubation at room temperature (RT) in the dark, all tubes were centrifuged 
and aspirated. The remaining pellets were resuspended in 0.5 mL permeabilization 
buffer and incubated at RT in the dark for 10 minutes. Then cells were washed with 
ice-cold washing buffer once. After centrifugation and aspiration, stimulated and 
unstimulated aliquots were incubated at RT in the dark for 30 minutes with either 5μL 
of anti-TNFα, anti-IL1β, anti-IL12 or isotype control IgG1 at saturating dilutions. 
After washing with washing buffer, cells were fixed with ice-cold fixation buffer and 
kept at 4 °C in the dark until measured (within 24 h). 
 
Sample labelling for measuring cytokines in lymphocytes and NK cells: 
After stimulation, stimulated and unstimulated samples were aliquoted (0.2 mL per 
polystyrene tube) and 1 mL lysing buffer was added to all tubes for lysing the red 
blood cells. After 5 minutes incubation at room temperature in the dark, all tubes were 
centrifuged and aspirated. The remaining pellets were resuspended in 0.5 mL  
permeabilization buffer and incubated at RT in the dark for 10 minutes. Then cells 
were washed with ice-cold washing buffer once. After centrifugation and aspiration, 
stimulated and unstimulated aliquots were incubated at RT in the dark for 30 minutes 
with anti-CD3 (5μL), anti-CD8 (5μL) and either anti-IFNγ, anti-IL2, anti-IL4, anti-
IL10 or isotype control IgG1 (5μL). Or aliquots were incubated with anti-CD3 (5μl), 
anti-CD94 (10μL) and either anti-IFNγ, anti-IL2, anti-IL4, anti-IL10 or isotype control 
IgG1 (5μL) at saturating dilutions. After washing with washing buffer, cells were 
fixed with ice-cold fixation buffer and kept at 4 °C in the dark until measured (within 
24 h). We have chosen to label NK cells with anti-CD94, for expression in CD56dim 
(cytolytic activity) as well as in CD56 bright (immunoregulation) NK cells (Jacobs R et 
al. 2001; Jacobs R et al. 2004; Cooper et al. 2001). 
 
Flow cytometry: 
Cells were analyzed using the Coulter Epics Elite flow cytometer (Argon-ion 488 nm 
laser). To minimize day-to-day variation of the measurements, the PE fluorescence 
(i.e. the label for the cytokine antibodies) was calibrated before each experiment using 
Standard Brite Beads (Coulter, Luton, UK). For each individual, two thousand 
lymphocytes were acquired by life gating on lymphocytes using forward and 
sidescatter characteristics and CD3+ cell signal. Data were saved for later analysis. 
Also for each individual, two thousand monocytes were acquired whilst life gating on 
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monocytes using CD14+ cell signal and saved for later analysis. In the samples for NK 
cells, thousand NK cells were acquired by gating lymphocytes using forward and 
sideward scatter and CD3-/ CD94+ cell signal. Analysis was performed using Winlist 




During analysis of lymphocytes and NK cells, a gate was set on lymphocytes using 
forward and sidescatter characteristics. Secondary gates were set on CD3+/CD8- (Th 
cells) and CD3+/CD8+ (Tc cells) or CD3-/CD94+ (NK cells) cells. For monocytes a 
gate was set on the CD14+ signal.  
For monocytes, Th, Tc and NK cells, single parameter fluorescence histograms were 
defined for evaluation of intracellular cytokine production. During analysis of all 
samples, it was found that the isotype control completely overlapped the unstimulated 
sample, indicating that cells in the unstimulated sample did not produce cytokines. 
Using the unstimulated control sample, linear gates were set in the histograms so that 
at least 99% of the unstimulated cells were negative for cytokine production. This gate 
was copied to the histogram for stimulated cells. Results are expressed as percentage 
positive cells in the stimulated blood sample.  
 
Differential blood cell counts: 
Using forward and sidescatter characteristics, a gate was set on the total leukocyte 
population. Using sidescatter characteristics as well as the CD14 antibody, we defined 
lymphocytes (low side scatter, CD14 negative), monocytes (strong CD14+ cells) and 
granulocytes (low CD14+ cells with a high sidescatter) in an unstimulated aliquot of 
each sample. The percentages of lymphocytes, monocytes and granulocytes of the 
total leukocyte population were evaluated. Within the lymphocyte population also the 
percentages of CD3+, CD3+/CD8+ and CD3+/CD8- and CD3-/CD94+ (NK cells) cells 
were evaluated. The absolute numbers of cells within of the various cell populations 
were calculated by multiplying the percentages with total number of white blood cells.   
 
Statistics: 
Results of the counts of white blood cells, granulocytes, monocytes and lymphocytes 
(overall, Th, Tc and NK cells) are expressed in the mean number of cells during the 
course of pregnancy. Results of the percentage cytokine-producing cells are expressed 
as mean ± standard error of the mean (SEM). To evaluate the relation between 
cytokine production and week of pregnancy, we used a linear or polynomial regression 
analysis (least sum of squares method). R2 and the slope were calculated and it was 
tested whether the slope was significantly different from zero. 
 





Figure 1a shows the white blood cell count (WBC). The WBC increased during the 
course of pregnancy (the slope of the regression line is 3.0). The mean of WBC in 
non-pregnant women was 548 ± 27 *107 cells/L, which was significantly lower than 
the mean WBC at 10, 15, 20, 25, 30, 35 and 40 weeks of pregnancy (P < 0.05, Mann-
Whitney U test). Also the number of granulocytes was increased during the course of  
pregnancy (fig. 1b). The slope of the regression line calculated from the mean number 
of granulocytes was 4.9, which differed significantly from zero (P = 0.02). 
Granulocytes in non-pregnant women were also significantly lower than the mean 
number of granulocytes at 10, 15, 20, 25, 30, 35 and 40 weeks of pregnancy (P < 0.05, 
Mann-Whitney U test). The number of monocytes was stable during pregnancy (fig. 
1c). The slope of the regression line calculated from the mean number of monocytes 
did not differ significantly from zero. Lymphocytes were also stable (fig. 1d). Also in 
this figure the slope of the regression line calculated from the mean number of 
lymphocytes did not significantly differ from zero. The mean number of lymphocytes 
in non-pregnant women was significantly lower as compared with 10 and 40 weeks of 
pregnancy. 
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R2 = 0.53; slope = 3.0
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R2 = 0.66; slope = 4.9 (P = 0.02)
b.
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Figure 1a-d. White blood cell count and granulocyte, monocyte and lymphocyte counts during the 
course of pregnancy. The line symbols the regression line of the mean number of cells. np = non-
pregnant women, p = pregnant women, * = significantly different from non-pregnant women (Mann-
Whitney U test P < 0.05). R2 = correlation coefficient. P < 0.05 = slope significantly different from zero.   
 
 
Figure 2a-c shows the cell counts of the lymphocyte subpopulations. The numbers of 
Th and Tc lymphocytes remained stable during pregnancy in this group (fig. 2a and 
2b). The slope of the regression line, calculated from the mean number of Th cells 
during pregnancy was 0.4 and the slope of the regression line, calculated from the 
mean number of Tc cells was -0.07, which was both not significantly different from 
zero. The mean number of Th and Tc cells in non-pregnant women was respectively 
84 ± 10 (107 cells/L) and 41 ± 5 (107 cells/L). The NK cells decreased dramatically 
during pregnancy (fig. 2c). The slope of the regression line calculated from the mean 
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number of NK cells was -0.53, which differed significantly from zero (P = 0.01). The 
mean number of NK cells in non-pregnant women was 22 ± 3 (107 cells/L), which was 
significantly higher than NK cells at 30, 35 and 40 weeks of pregnancy.  



















































































Figure 2a-c. Mean numbers of peripheral lymphocyte subtypes: Th, Tc and NK cells during the course 
of pregnancy. The line symbols the regression line of the mean number of cells.  np = non-pregnant 
women, p = pregnant women, * = significantly different from non-pregnant women (Mann-Whitney U 




Percentage cytokine-producing monocytes during normal pregnancy 
Fig. 3a-c shows the cytokine production in stimulated monocytes during pregnancy. 
The TNFα production of monocytes remained stable (fig. 3a). The R2 was 0.15. No 
significant difference was observed between pregnant women as compared with non-
pregnant women. The IL1β production decreased slowly during pregnancy and may 
increase slightly after 35 weeks of pregnancy (fig. 3b). The best fit curve was not a 
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linear, but a polynomial curve. The R2 was 0.60. Also in IL1β-producing stimulated 
monocytes, no significant change was seen in pregnant women as compared with non-
pregnant women. The curve of the IL12-producing stimulated monocytes was 
different compared to the relatively straight line of TNFα- and IL1β-producing 
stimulated monocytes. The curve of the stimulated IL12-producing monocytes was 
also calculated polynomial. 
The production of IL12 increased until 15-17 weeks, then decreased until 35 weeks, 
after which an increase in IL12 production was seen (fig. 3c). The production of IL12 
was significantly decreased at 30 and 35 weeks of pregnancy as compared with non-
pregnant women.  













































































Figure 3a-c. Mean percentage of cytokine-producing monocytes after stimulation of whole blood with 
LPS in pregnant women through the course of pregnancy (triangles) and in non-pregnant women 
(squares). Fig. 3a represents the mean percentage TNFα-producing monocytes. Fig. 3b represents the 
mean percentage IL1β-producing monocytes. Fig. 3c represents the mean percentage IL12-producing 
monocytes. np = non-pregnant, p = pregnant. * = significantly different from non-pregnant women 
(Mann-Whitney U test P < 0.05). R2 = correlation coefficient. P < 0.05 = slope significantly different 
from zero.   
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Percentage cytokine-producing lymphocytes and NK cells during normal pregnancy  
Figure 4a-d shows the cytokine production of stimulated Th cells. Fig. 4a shows the 
IFNγ production of Th cells during pregnancy. Through the course of pregnancy a 
significant decrease was seen in IFNγ production. The slope of the regression line 
calculated from the mean number of IFNγ-producing Th cells was -0.33, which 
significantly differed from zero (P = 0.0019). The R2 of the regression line of the Th 
cells was 0.87. Although the production slowly decreased during pregnancy, there was 
no significant difference between values from pregnant women as compared with non-
pregnant women. In fig. 4b the IL2 production of Th cells is shown during pregnancy. 
A significant decrease in IL2 production was seen at 10, 30 and 35 weeks of 
pregnancy as compared with non-pregnant women (fig. 4b).   
The regression line of IL4-producing Th cells is shown in fig. 4c. The R2 was 0.79.  
The best fit regression line was obtained by polynomial calculation. A significant 
difference was shown between 40 week’ pregnant and non-pregnant women.  
In fig. 4d the (polynomial calculated) regression line is shown for IL10-producing Th 
cells. The R2 was 0.80. 
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Figure 4a-d. Mean percentage cytokine-producing Th cells after stimulation with PMA (40 nM) and 
calcium ionophore (2 nM). Fig. 4a represents the mean percentage IFNγ-producing Th cells. Fig. 4b 
represents the mean percentage IL2-producing Th cells. Fig. 4c represents the mean percentage IL4-
producing Th cells. Fig. 4d represents the mean percentage IL10-producing Th cells. np = non-
pregnant, p = pregnant. * = significantly different from non-pregnant women (Mann-Whitney U test P < 
0.05). R2 = correlation coefficient. P < 0.05 = slope significantly different from zero.   
 
 
Fig. 5a-d shows the cytokine production of stimulated Tc cells. In fig. 5a, a decrease is 
seen in IFNγ-producing Tc lymphocytes through the course of pregnancy. The slope 
of the regression line calculated from the mean number of IFNγ-producing Tc cells 
significantly differed from zero (P = 0.031). No significant difference was seen as 
compared with non-pregnant women. In fig. 5b the IL2 production of stimulated Tc 
cells showed a slight increase until 25 weeks, followed by a slight decrease until the 
end of pregnancy. A significant difference was seen in IL2-producing Tc lymphocytes 
of non-pregnant women as compared with 10, 30 and 35 weeks of pregnancy (fig. 5b). 
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In fig. 5b-d the best fit polynomial curves were calculated. For IL4 and IL10 a sinus-
like curve was seen. The R2 was 0.73 in both cases (fig. 5c-d). In the first trimester of 
pregnancy the percentage of IL4-producing Tc cells reached a top. No significant 
difference was seen compared to non-pregnant women. Fig. 5d also shows a sinus-like 
curve. The highest percentage of IL10-producing Tc cells was in the third trimester of 
pregnancy. Also in the IL10-producing Tc cells no significant difference was seen 
compared with non-pregnant women.  





































































































Figure 5a-d. Mean percentage cytokine-producing Tc cells after stimulation with PMA (40 nM) and 
calcium ionophore (2 nM)  Fig 5a represents the mean percentage IFNγ-producing Tc cells. Fig. 5b 
represents the mean percentage IL2-producing Tc cells. Fig. 5c represents the mean percentage IL4-
producing Tc cells. Fig. 5d represents the mean percentage IL10-producing Tc cells. np = non-pregnant, 
p = pregnant. * = significantly different from non-pregnant women (Mann-Whitney U test P < 0.05). R2 
= correlation coefficient. P < 0.05 = slope significantly different from zero.   
 
Fig. 6a-d shows the cytokine production of stimulated NK cells. In fig. 6a, a decrease 
was seen in IFNγ-producing NK cells during pregnancy. The R2 was 0.68 and the 
slope of the regression line calculated from the mean number of IFNγ-producing NK 
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cells significantly differed from zero (P = 0.02). The IFNγ production of non-pregnant 
women was significantly higher than at 20, 25, 30, 35 and 40 weeks of pregnancy. In 
the IL2-producing NK cells an increase in production was seen until 30 weeks of 
pregnancy (fig. 6b). The R2 was 0.88. In fig. 6b the best fit curve was calculated 
polynomial, instead of linear. 
Significant difference was seen in the non-pregnant production of IL2 as compared 
with the production at 15 weeks of pregnancy (fig. 6b). After 30 weeks a decrease was 
seen in the IL2 production of NK cells. In the NK cells producing IL4 an increase in 
production was seen from 15 until 30 weeks of pregnancy (fig. 6c). The R2 of the 
polynomial curve was 0.53. In the IL4-producing NK cells a significant decrease was 
seen compared with non-pregnant women at 20, 25 and 40 weeks of pregnancy (fig. 
6c). In the NK cells producing IL10 an increase in production was seen until 30 weeks 
of pregnancy (fig. 6d). The R2 of the polynomial curve was 0.69. IL10-producing NK 
cells in non-pregnant women showed a significant difference at 10 weeks of 
pregnancy (fig. 6d).  













































































































Figure 6a-d. Mean percentage of cytokine-producing NK cells after stimulation with PMA (40 nM) and 
calcium ionophore (2 nM). Fig. 6a represents the mean percentage IFNγ-producing NK cells. Fig. 6b 
 - 88 - 
 
represents the mean percentage IL2-producing NK cells. Fig. 6c represents the mean percentage IL4-
producing NK cells. Fig. 6d represents the mean percentage IL10-producing NK cells. np = non-
pregnant, p = pregnant.  
* =  significantly different from non-pregnant women (Mann-Whitney U test P < 0.05). R2 = correlation 





The immune system plays a crucial role in the progress of normal pregnancy. The 
foetus is from an immunologic point of view semi-allogeneic and it might be 
suggested for preventing rejection, the mother has to adapt her immune system. 
Besides, immune cells at the implantation/placentation site, peripheral immune cells, 
such as monocytes, T lymphocytes and NK cells, are suggested to play an important 
role in the adaptation to pregnancy (Weetman 1999; Szekeres-Bartho 2002). The present 
study demonstrates that in pregnant women as compared with non-pregnant women, 
the number of WBC increases during the course of pregnancy, which is due to an 
increasing number of granulocytes. Also the number of cytokine-producing monocytes 
after stimulation, as well as the number of cytokine-producing T lymphocytes and NK 
cells after stimulation, change during the course of pregnancy. The most obvious 
effect of pregnancy is the decreasing percentage of IFNγ-producing lymphocytes 
during the course of pregnancy. Moreover, the percentages IL10- and IL4-producing 
lymphocytes and NK cells appear to peak around week 30.  
 
In monocytes the TNFα, IL12 and IL1β cytokine production was measured after 
stimulation with LPS. Although in this study at no point during pregnancy the 
percentage of IL1ß-producing monocytes differed from non-pregnant women, they 
appeared to decrease from 10 until 35 weeks of pregnancy and increased just before 
delivery. This may indicate monocyte activation during pregnancy (Luppi et al. 2002; 
Veenstra van Nieuwenhoven et al. 2003). Activated monocytes may show LPS-tolerance 
which is characterized by a decreased cytokine production following LPS-stimulation 
(Munoz et al. 1991; Van der Poll et al. 1992). The increase of the number of IL1ß-producing 
monocytes just before parturition may be explained as a preparation for labour. IL1β 
could stimulate the synthesis of prostaglandines and in this way trigger cervical 
dilatation and myometrial contraction (Baggia et al. 1996). In accordance with this 
suggestion, Luppi et al. showed that monocytes and granulocytes increase their 
expression of CD11b after 37 weeks of pregnancy (Luppi et al. 2004). The up-regulation 
of this adhesion molecule may be important to guide the inflammatory cells towards 
the reproductive tract in preparation of labour.  
 
The percentage of IL12-producing monocytes seemed to follow a sinus-like curve, 
with a peak at 15 weeks of pregnancy and a significant nadir at 30-35 weeks. The 
increase of IL12-producing monocytes in the first trimester of pregnancy was also 
demonstrated in another study (Zenclussen et al. 2002). Although the reason for the 
increased percentage of  IL12-producing monocytes in the beginning of pregnancy is 
unknown, it seems extremely important for normal pregnancy, since a decreased 
percentage IL12-producing monocytes is associated with recurrent spontaneous 
abortions (Zenclussen et al. 2002).  It is known that IL12 can stimulate the production of 
IFNγ (Tripp et al. 1993; Ahn et al. 1997; Diouf et al. 2007), which is an important cytokine for 
the trophoblast invasion into spiral arteries (Ashkar et al. 2000). It is suggested that the 
increased IL12 production in the first trimester may be important for stimulation of 
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IFNγ production and thus trophoblast invasion into the spiral arteries (Trinchieri 1993). 
After 15 weeks of pregnancy, the percentage of IL12-producing monocytes seemed to 
decrease towards week 30-35. The percentages of IL12-producing monocytes were 
significantly decreased at 30 and at 35 weeks of pregnancy compared to the 
percentages found in non-pregnant women. Similar findings had been observed 
previously (Elenkov et al. 2001; Veenstra van Nieuwenhoven et al. 2003). As suggested above 
for IL1β- producing monocytes, this decreased percentage IL12-producing monocytes 
around 30-35 weeks of pregnancy could be a sign of activation of monocytes. 
Towards the parturition, IL12 seemed to increase again, which may suggest a role for 
IL12 in inducing labour.  
Percentages of TNFα-producing monocytes appeared constant throughout pregnancy 
in this study. This is in line with findings from other studies which also showed that 
the percentage of TNFα-producing monocytes after LPS-stimulation did not vary 
during pregnancy (Sacks et al. 2003, Luppi et al. 2002). It is, however, in contrast with our 
previous study in which the percentage of TNFα-producing monocytes was decreased 
at 30 weeks of pregnancy as compared with non-pregnant women (Veenstra van 
Nieuwenhoven et al. 2003). The reason for this discrepancy is unclear.  
 
Some studies have demonstrated a decrease of the IFNγ production by lymphocytes at 
the end of pregnancy (Marzi et al. 1996; Reinhard et al. 1998; Veenstra van Nieuwenhoven et al. 
2002). The present study showed a decreasing IFNγ production after stimulation of Th 
and Tc lymphocytes as well as NK cells during the course of pregnancy. These 
findings are in line with the suggestion that type 1 cytokines are detrimental to 
pregnancy and consequentially the production of stimulated type 1 cells is decreased 
during pregnancy (Hill et al. 1995; Raghupathy et al. 1997). This decreased IFNγ production 
during pregnancy is suggested to be due to a decreased NF-kappa B activity (McCracken 
et al. 2004). Interestingly, it appears that this decrease of type 1 cytokine production in 
lymphocytes and NK cells correlates negatively with the increase in trophoblast mass 
during pregnancy. This suggests that the trophoblast regulates type 1 cytokine 
production. Steroid hormones produced by the trophoblast could be responsible for 
this down-regulation. Progesterone and oestrogen steadily increase during pregnancy 
and decrease just before labour (Branch 1992; Doria et al. 2004). Progesteron (Piccini et al. 
2000) and oestrogen (Salem et al. 2000) inhibited type 1-mediated immune responses and 
stimulate type 2-mediated immune responses. Moreover, trophoblast cells are known 
to produce type 2 cytokines (Sacks et al. 2001) which can also down-regulate type 1 
cytokines (Bennet et al. 1999). Finally, the shedding of microfragments from the 
trophoblast is increased during pregnancy. Potentially such microfragments could 
affect the production of cytokines by lymphocytes (Germain et al. 2007).  
The continuous decreased production of IL2 after stimulation of Th and Tc 
lymphocytes was also found in other studies (Veenstra van Nieuwenhoven et al. 2002; Walker 
et al. 2002; Darmochwal-Kolarz et al. 2002). This decrease in percentage IL2-producing 
lymphocytes is also in line with the suggestion that type 1 cytokines are harmful for 
pregnancy. It has been demonstrated that the stimulated production of IL2 by 
lymphocytes can be inhibited by oestrogen (McMurray et al. 2001). It may therefore be 
suggested that the increased oestrogen concentrations during pregnancy are 
responsible for the decreased percentage IL2-producing lymphocytes during 
pregnancy.  
 
During the course of pregnancy we observed a sinus-like curve for percentages of IL4- 
producing Th and Tc lymphocytes with a nadir around week 20 weeks of pregnancy 
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and a peak around 30 weeks. Towards parturition, percentages IL4-producing 
lymphocytes decreased again. This was, however, only significant for Th 
lymphocytes. Also Wilke et al. showed an up-regulation of IL4 production followed by 
a suppression of IL4 production towards the end of pregnancy (Wilke et al. 2006). 
Similarly, the percentage IL10-producing lymphocytes appeared to peak at 25-30 
weeks of pregnancy and decreased towards parturition. The down-regulation of type 2 
cytokines from 35 weeks of pregnancy, observed in Th and Tc lymphocytes, may be a 
preparation for labour. Together with the up-regulation of proinflammatory cytokines 
in monocytes, this may create a proinflammatory milieu necessary for parturition 
(Keski-Nisula et al. 2000; Bowen et al. 2002; Gravett et al. 2007). Although the exact 
mechanism of down-regulation of type 2 cytokines towards delivery is unknown, it 
may be related to the concentration of β-HCG at the end of pregnancy. A recent study 
by Edelstam et al. demonstrated that β-HCG decreased by almost 50 % during the last 
weeks of pregnancy (Edelstam et al. 2007). They suggested that this could be the trigger 
for uterus contractions. However, decreased β-HCG may also result in decreased 
indoleamine 2, 3-dioxygenase (IDO) production (Ueno et al. 2007; Lei et al. 2007; Xu et al. 
2008). IDO is a catalysator of the breakdown of tryptophan in villous circulation (Kudo 
et al. 2004; Ligam et al. 2005). Since IDO may promote type 2 responses, decreased IDO 
may result in decreased type 2 cytokine production.  
 
Peripheral NK cells may play an important role in pregnancy. The number and activity 
of peripheral NK cells is increased for instance in women with spontaneous recurrent 
abortion, suggesting a role for these cells in spontaneous miscarriage (Matsubayashi et al. 
2005; Agarwal et al. 2006; Perricone et al. 2006). Indeed in our study the number of NK cells 
decreased during the course of pregnancy which suggests that total cytolytic activity is 
probably decreased during pregnancy. Also other studies found a decreased number of 
NK cells during pregnancy (Hidaka et al. 1991; Veenstra van Nieuwenhoven et al. 2002). Not 
only the number of peripheral NK cells decreased during the course of pregnancy but 
also the percentage of IFNγ-producing NK cells was significantly decreased during 
pregnancy, which is in agreement with a previous study from our lab (Veenstra van 
Nieuwenhoven et al. 2002). It is also in agreement with the results for T lymphocytes,  
showing a decreased stimulated IFNγ production. Also the percentage of IL2-
producing NK cells seemed to be decreased in pregnancy. As described above, IFNγ 
production in NK cells correlates negatively with the increase in trophoblast mass. 
Indeed, the decreased production of type 1 cytokines by NK cells can possibly be 
explained by the effects of oestrogen and progesterone, since peripheral NK cells 
produced less IL2 and IFNγ in menopausal women after oestrogen/progesterone 
therapy than before (Stopinska-Gluszak et al. 2006).  
 
The percentages of IL4- and IL10-producing NK cells seemed to be decreased during 
pregnancy. Although the percentages of IL4- and IL10-producing NK cells seemed to 
be decreased in pregnant women as compared with non-pregnant women, the curves 
of percentages of both IL4- and IL10-producing NK cells were sinus-like, with a nadir 
around 10-15 weeks of pregnancy and a peak around 30 weeks. The nadir in IL10- 
producing NK cells is in contrast with a study of Higuma-Myojo (Higuma-Myojo et al. 
2005). They found a sharp increase in IL10-producing NK cells in early pregnancy. The 
discrepancy in results may be due to differences in methodology. The decrease after 
30 weeks of pregnancy may again be related to labour. As indicated above, in this 
phase of pregnancy it is known that β-HCG decreases, which results in a down-
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regulation of IDO. This down-regulated IDO may skew cytokine responses of NK 
cells towards a type 1 profile (Molano et al. 2008).  
 
Notably, in the present study the peak in stimulated cytokine production of IL10 and 
IL4 is at around 30 weeks of pregnancy in lymphocytes and NK cells. It is unknown 
what mechanism causes this peak in cytokine production. However, it can be 
speculated that this peak in cytokine production may be related to the stretching of the 
foetal membranes or start of foetal lung ripening. Both processes start around 30 
weeks of pregnancy (Wiehle et al. 1995). Foetal membranes grow until around 28 weeks 
of pregnancy (Parry-Jones and Priya 1976). After this time, foetal membranes begin to 
stretch rather than grow and can stretch about 70% at term (Millar et al. 2000). It has 
been shown that the stretching of foetal membranes can affect the expression of a 
number of cytokines and enzymes, for example prostaglandin E2 (PGE2), IL8 (El 
Maradny et al. 1996; Nemeth et al. 2000a,b). From 30 weeks of pregnancy onwards, also 
foetal lung ripening starts. Pulmonary surfactant, a phospholipid-rich lipoprotein 
produced by lung cells, reduces surface tension at the alveolar air-liquid interface 
which is essential for normal breathing (Daniels and Orgeig 2003). This surfactant is 
produced in the foetus from 30 weeks of pregnancy onwards. Although the exact 
relationship between surfactant production and type 2 cytokines is unclear, it is 
interesting to note that is has been hypothesized that surfactant may be the trigger of 
parturition by activation of the inflammatory response (Condon et al. 2004).   
 
From the present study we conclude that cytokine production by peripheral immune 
cells varies during normal pregnancy, which may reflect the changing contact between 
mother and foetus during pregnancy. Our first measurements of cytokine production 
were at 10 weeks of pregnancy. This is around the time when the utero-placental 
circulation starts to develop. Changes seen at that time, such as decreased production 
of some type 2 cytokines, as compared with non-pregnant women, do probably relate 
to this development. Interestingly, it appears that the increase in trophoblast mass 
correlates (negatively) with a decrease in type 1 cytokine-producing cells and not with 
type 2 cytokine-producing cells, suggesting that the trophoblast, directly or indirectly, 
regulates type 1 cytokine production. Just before parturition, it seems that both 
monocytes- and lymphocyte cytokine production change towards an increased 
production of proinflammatory cytokines (IL1β and IL12) by monocytes and a 
decreased production of type 2 cytokines by lymphocytes. This may be a preparation 
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